BioWorld MedTech

April 22, 2011

Riverain software gives clearer picture for lung cancer detection

Riverain Medical (Miamisburg, Ohio) is providing clinicians and radiologists with the perfect back-up plan to detect lung cancer in patients – and it has a peer-reviewed study to prove it. (Medical Device Daily) Read More

Healthcare industry may soon see increased M&A activity

Washington roundup: FDA strategic plan still lacks details on enforcement plans

Shared EHRs are blocked by incompatibility of med-tech

International report: Orthocon's Hemasorb cleared for sale in Europe and Canada

MDD's food for med-tech thought

Agreements/contracts: Corindus robot added to Philips cardiology solutions

Med-Tech Notes

Restructuring roundup: Anulex initiates layoffs to adjust to FDA warning letter

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...